News

Nutrilipid 20% is indicated as a source of calories and essential fatty acids for parenteral nutrition and also as a source of essential fatty acids when a deficiency

MigraPure, which is packaged in pre-measured UnitDose sachets, is a doctor-recommended homeopathic formulation of feverfew and ginger that offers highly effective relief of migraine pain and associated symptoms.

Currently, AG-221 is being evaluated in a Phase I clinical trial in patients with advanced hematologic malignancies. Agios chief medical officer Chris Bowden said the company believes this

RP101 is a proprietary, first-in-class, heat shock protein 27 (Hsp27) inhibitor, administered orally, which may prevent the induction of resistance to chemotherapy (chemoresistance), thus maintaining sensitivity of the

The signing of the supplemental agreement accelerates clinical trial development in both America and China, for IRT-101 ("MENK"). In the hope of moving clinical development forward the parties

These options represent an additional $4.1 million to BioCryst in order to advance the development of BCX4430 as a treatment for hemorrhagic fever viruses. NIAID, part of the

"The claims included in this Notice of Allowance continue to expand the strength of the VIMOVO patent estate and add to our ability to protect VIMOVO innovation in

The data demonstrated a visual acuity and anatomical benefit for the group of patients receiving the combination of OHR-102 and Lucentis(R) PRN ("OHR-102 arm") versus placebo eye drops

Reprogenetics will announce this to clients at the Florida Society of Reproductive Endocrinology and Infertility Meeting (FSREI), Saturday, August 16 at The Ritz-Carlton in Orlando. Rounding out its